New Study Throws Light On Male Breast Cancer

by Paromita Datta published on -

Male breast cancer (MBC) accounts for less than 1 percent of breast cancer cases. That perhaps explains the lack of knowledge and research regarding MBC. However, we do understand that the biology of the MBC differs from female breast cancer, which means that we must study it separately. A recent wide-ranging cohort study, published in the journal Cancer, now sheds some light on the treatment and prognosis of MBC patients in the US. [1]

The research was based on the National Cancer Data Base. Data on 10,873 patients diagnosed with stage I to stage III MBC between 2004 – 2014 was gathered and analyzed. The team found that the average age at which MBC is diagnosed is in the mid-60s. Most patients were diagnosed in stage I or II. 89 percent of the patients were ER+. More than two-thirds of the patients underwent a mastectomy. This is significantly higher than the one-third of female breast cancer patients who go for mastectomy.

A man holding a pink cancer ribbon standing against a pink background

62 percent patients with ER+ tumors went for anti-estrogen therapy. 24 percent of patients received breast-conserving surgery and of these, 70 percent had to go through radiation. 44 percent patients received chemotherapy. Factors that affected survival were race, age, multiple comorbidities, total mastectomy, tumor grade and stage. Treatment has evolved over the years, concluded the study. Protection Status
Last updated -
About the Author

Paromita Datta covers the latest health and wellness trends for Organic Facts. An ex-journalist who specialized in health and entertainment news, Paromita was responsible for managing a health supplement for The New Indian Express, a leading national daily in India. She has completed her post-graduation in Business Administration from the University of Rajasthan and her diploma in journalism from YMCA, Delhi. She has completed an e-course, Introduction to Food and Health, from Stanford University, US.

Rate this article
Average rating 0.0 out of 5.0 based on 0 user(s).